APAC Cardiac Ablation Market size is expected to reach USD 1.9 billion By 2028, according to a latest forecast report by Graphical Research.
Rapid technological advancements that enhance efficiency and accuracy will accelerate the cardiac ablation adoption rate. Continuous advancements in technology offer ease of use, minimal pain, and fewer post-procedural complications that will augment the patient preference towards minimally invasive cardiac ablation procedures. Thus, the growing availability of advanced technology that enables cardiac ablation products in healthcare facilities will positively influence the market revenue growth. Moreover, high investment by the key business players for the development of novel cardiac ablation products will impel the regional industry growth.
Growing pervasiveness of cardiovascular disorders with a high risk of severe health concerns such as myocardial infractions will propel the market demand. Thus, the increasing government initiatives for awareness regarding cardiac devices and related diseases will spur the industry growth. For instance, the Ministry of Health & Family Welfare of India launched a national programmer for prevention & control of cancer, diabetes, cardiovascular diseases & stroke (NPCDCS) to strengthen healthcare infrastructure in the country, early disease diagnosis, and management, health promotion, human resource development in the country to reduce the burden of non-communicable diseases. Such awareness campaigns create awareness and educate people regarding heart complications and related treatments in the country to minimize chronic disease burden.
The ultrasound ablators segment accounted over USD 11 million revenue in 2021. Several benefits associated with ultrasound cardiac ablation procedures like minimal biomechanical effect reduces procedural time and enhance convenience. Furthermore, the integration of numerous advanced technologies such as high-intensity focused ultrasound (HIFU) and extracorporeal shock wave therapy (ECWT) in cardiac ablation procedures for better patient outcome and ease of use will stimulate the overall market size. Continuous advancements in ultrasound ablators and increasing new product developments will further augment the market revenue.
The open/surgical segment will expand at 13.3% CAGR during the forecast timeframe. The segment is contemplated to reach significant market growth with the need for continuous cardiac ablation procedures among patients with atrial fibrillation and several other cardiovascular complications. Furthermore, increasing the patient pool with heart diseases will positively impact the industry. High adoption of surgical approaches in underdeveloped and developing countries for disease treatment will majorly drive the market value.
Browse detailed statistical insights from the report, “Asia Pacific Cardiac Ablation Market Forecast 2028 By Approach (Catheter-based, Open/Surgical), By Product (Radiofrequency (RF) Ablators, Electrical Ablators, Cryoablation Devices, Ultrasound Ablators), , By Application (Atrial Fibrillation & Flutter, Tachycardia), By End-use (Hospitals, Ambulatory Surgical Centers, Cardiac Centers), Research Report, Country Outlook (China, Japan, India, Australia, South Korea, Malaysia, Indonesia, Thailand, Singapore, Taiwan, Philippines, Vietnam), COVID-19 Impact Statistics, Country Outlook, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share” along with the table of contents (ToC) @
Based on application, others segment held over 42% market share in 2021. Others segments include cardiac arrhythmia, Wolff-Parkinson-White syndrome, etc. The rising prevalence rate of arrhythmia in the region will proliferate the industry outlook. Additionally, the growing aging population that is prone to several cardiovascular diseases in the region. Increasing accessibility to highly developed ablators for cardiac treatment in healthcare settings will enhance the market demand.
Cardiac centers segment was valued at USD 138 million revenue in 2021 owing to the growing network of specialty facilities for cancer management across the region. Expanding cardiac centers to cater to a large patient pool in the developing economies will propel the segmental demand. Easy availability and broader accessibility of the products in facilities will further offer lucrative growth opportunities.
India cardiac ablation industry will witness 15.4% CAGR through 2028. A favorable regulatory scenario for the development of cardiac ablation in the country will offer development opportunities to the market players. Moreover, growing awareness regarding cardiovascular diseases with several government initiatives will positively impact the adoption rate. Further, growing trends of westernization, unhealthy dietary habits, high consumption of caffeine and high usage of herbal remedies will spur the incidence of cardiovascular diseases thereby, accelerating demand for cardiac ablation procedures in the country. Moreover, with increasing per capita income, developing healthcare infrastructure, and high healthcare expenditure.
Asia Pacific cardiac ablation market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2017 to 2028, for the following segments:
Asia Pacific Market, By Product
- Radiofrequency (RF) ablators
- Electrical ablators
- Cryoablation devices
- Ultrasound ablators
Asia Pacific Market, By Approach
Asia Pacific Market, By Application
- Atrial fibrillation & flutter
Asia Pacific Market, By End-use
- Ambulatory surgical centers
- Cardiac centers
The above information has been provided for the following countries:
- Asia Pacific
- South Korea